IDXG - Interpace Biosciences - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Interpace Biosciences's activity chart (see below) currently has 3 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from HC WAINWRIGHT on 18-Nov-2021. First documented stock forecast 24-Sep-2018.

Yi Chen Jason Mccarthy

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 18-Nov-2021

$12

4 years 9 months 24 days ago
(18-Nov-2021)

0/1 (0%)

$6.11 (103.74%)

Buy Since 24-Sep-2018

$40

$38.35 (2324.24%)

7 years 11 months 18 days ago
(24-Sep-2018)

0/1 (0%)

$39.84 (24900.00%)

Show more analysts

Which analyst most recently updated their price target on IDXG (Interpace Biosciences)?

Which analyst has the most public recommendations on IDXG (Interpace Biosciences)?

has 0 price targets and 0 ratings on IDXG

Which analyst is the currently most bullish on IDXG (Interpace Biosciences)?

Jason Mccarthy with the highest potential upside of $38.35

Which analyst is the currently most reserved on IDXG (Interpace Biosciences)?

Yi Chen with the lowest potential downside of -$0